296.88
price up icon0.60%   1.78
after-market Dopo l'orario di chiusura: 297.30 0.42 +0.14%
loading

Amgen Inc Borsa (AMGN) Ultime notizie

pulisher
Aug 03, 2025

Amgen's Q2 Earnings: A Critical Inflection Point for Biotech's Leading Innovator - AInvest

Aug 03, 2025
pulisher
Aug 03, 2025

Earnings To Watch: Amgen (AMGN) Reports Q2 Results Tomorrow - TradingView

Aug 03, 2025
pulisher
Aug 03, 2025

Tredje AP fonden Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

Amgen Inc. Stock Analysis and ForecastDiscover high-impact investment opportunities - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Sold by Malaga Cove Capital LLC - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

J. Safra Sarasin Holding AG Increases Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

Mitsubishi UFJ Trust & Banking Corp Purchases 7,308 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

Amgen Inc. (NASDAQ:AMGN) Position Increased by PNC Financial Services Group Inc. - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

Fiduciary Wealth Partners LLC Purchases New Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

Endeavor Private Wealth Inc. Has $920,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

What markets is CRUS expanding into Is Amgen Inc. stock a good long term investment optionExceptional growth trajectory - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 02, 2025

Amgen Inc. to Issue Quarterly Dividend of $2.38 (NASDAQ:AMGN) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Amgen (AMGN) Board Declares US$2.38 Dividend for Q3 2025 - simplywall.st

Aug 02, 2025
pulisher
Aug 02, 2025

Moors & Cabot Inc. Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Heritage Wealth Advisors Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Sold by Commerce Bank - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

US Bancorp DE Sells 6,952 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Hoxton Planning & Management LLC Purchases Shares of 968 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Baader Bank Aktiengesellschaft Has $279,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Bought by XTX Topco Ltd - MarketBeat

Aug 02, 2025
pulisher
Aug 01, 2025

Federated Hermes Inc. Has $634.68 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

UBS Raises PT on Amgen Inc. (AMGN) to $326 From $315, Keeps a Neutral Rating - MSN

Aug 01, 2025
pulisher
Aug 01, 2025

Banque Cantonale Vaudoise Acquires New Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen Announces $2.38 Per Share Dividend Payout: Key Dates and Details Revealed - Stock Titan

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Promising Phase 3 Study on Dazodalibep for Sjögren’s Syndrome: A Potential Game-Changer - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Latest Clinical Study: A Potential Game-Changer in Lung Cancer Treatment? - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Tarlatamab Study: A Potential Breakthrough in SCLC Treatment - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Promising Heart Failure Study: A Potential Game-Changer? - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Promising Phase 3 Study for Metastatic Colorectal Cancer - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s New Study on AMG 410: A Potential Game-Changer in Cancer Treatment - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s New Melanoma Study: A Potential Game Changer? - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatment - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Promising Phase 3 Study on Weight Loss Drug Maridebart Cafraglutide - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s AMG 193 Study: A Potential Game-Changer in Thoracic Tumor Treatment - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s CodeBreaK 202: A New Front-Line Therapy Study for Advanced Lung Cancer - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Phase 2 Study on HZN-1116: A Potential Breakthrough for Sjögren’s Syndrome - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Golden Gate Study: A Promising Leap in Leukemia Treatment - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s Phase 3 Obesity Drug Trial: A Potential Game Changer? - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen’s New Study on ABP 234: A Potential Game-Changer in Lung Cancer Treatment - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Is Amgen (NASDAQ:AMGN) A Risky Investment? - simplywall.st

Aug 01, 2025
pulisher
Aug 01, 2025

Torray Investment Partners LLC Trims Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Natixis Advisors LLC Has $101.15 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Should I hold or sell Amgen Inc. stock in 2025Free Stock Review For Consistent Profits - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Arkadios Wealth Advisors Boosts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Dearborn Partners LLC Has $654,000 Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Why Amgen Inc. stock attracts strong analyst attentionReliable Breakout Signal Guide Signal - beatles.ru

Aug 01, 2025
pulisher
Aug 01, 2025

Geneos Wealth Management Inc. Purchases 5,500 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Bought by Marco Investment Management LLC - MarketBeat

Aug 01, 2025
pulisher
Jul 31, 2025

Mitchell Sinkler & Starr PA Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Foundations Investment Advisors LLC Increases Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Mackenzie Financial Corp Has $55.12 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Amgen’s Promising Oncology Study: A Closer Look at AMG 193 and IDE397 - MSN

Jul 31, 2025
pulisher
Jul 31, 2025

Amgen Sets Q2 2025 Earnings Call: CEO Bradway to Present Financial Results August 5 - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

LPL Financial LLC Acquires 75,636 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Woodard & Co. Asset Management Group Inc. ADV Sells 1,157 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Why is Amgen Inc. stock attracting strong analyst attentionRetirement Planning Review With Proven Results - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

How strong is Amgen Inc. company’s balance sheetDaily Trading Signals That Work - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Gear Up for Amgen (AMGN) Q2 Earnings: Wall Street Estimates for Key Metrics - Yahoo.co

Jul 31, 2025
pulisher
Jul 31, 2025

Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

Howard Capital Management Inc. Has $5.58 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Vestcor Inc Sells 6,075 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

TD Asset Management Inc Sells 27,366 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Purkiss Capital Advisors LLC Buys Shares of 863 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Jul 31, 2025
drug_manufacturers_general NVO
$48.19
price up icon 2.38%
$113.18
price up icon 0.79%
drug_manufacturers_general PFE
$23.49
price up icon 0.86%
drug_manufacturers_general MRK
$79.29
price up icon 1.50%
drug_manufacturers_general SNY
$46.75
price up icon 2.43%
Capitalizzazione:     |  Volume (24 ore):